-
challenges. Partners include universities, hospitals, and international research organizations. In its national strategic plan, Inserm has identified four key priorities: (i) strengthening the continuum
-
to tissue remodeling during disease will generate innovative fundamental knowledge while opening new therapeutic perspectives. This chair will rely on close interactions with clinicians at Necker Hospital in
-
translating scientific advances into concrete applications with clinical or economic impact. Experience in innovation management, translational research, or interaction with technology-transfer offices will be
-
approaches to complex chronic diseases. It fits fully within the priorities of the Inserm Strategic Plan, particularly the axis dedicated to cardiovascular and brain health and integrative approaches
-
during international congresses, and animation of scientific events in France and abroad. - Strengthen knowledge transfer and innovation by promoting interactions with clinical, institutional and
-
challenges. Partners include universities, hospitals, and international research organizations. One of Inserm's priorities in its 2025 strategic plan (priority 1, objective 2) is to promote disruptive research
-
chemical contaminants during massive weight loss, to better understand the interactions between the metabolic and chemical exposome in the early programming of health. The project will require the design and
-
Innovation in cancer Immunology) address the scientific challenges raised by cancer immunotherapy. A better understanding of the interactions between immune cells and tumor microenvironment should allow us to
-
at Sorbonne Paris Nord University will align with this strategic plan. Translational approaches ranging from fundamental to clinically oriented research will be the core of the “Chaire” project. The candidate